The results of semiquantitative immunofluorescence analysis showed that the fluorescence intensity of TRPC3 in the BPD group was lower than that in the control group on days 10 and 14 (p < 0.01) (Figure 3B), which was consistent with the results of qPCR and WB. Here, TRPC3 is linked to bronchopulmonary dysplasia.